Drug intelligence / Profile preview

paromomycin + domperidone

Development stage
Unknown
Lead developer
Appili Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination of two drugs, paromomycin and domperidone. Paromomycin is an aminoglycoside antibiotic primarily used to treat acute and chronic intestinal amebiasis (a parasitic infection of the intestines) and as adjunctive therapy for hepatic coma. It works by inhibiting protein synthesis in susceptible bacteria and parasites, leading to their death[1][2][3]. Domperidone is a dopamine receptor antagonist that acts as a peristaltic stimulant and antiemetic agent. It increases gastrointestinal motility, relieves symptoms such as nausea, vomiting, bloating, and discomfort due to delayed gastric emptying or gastroparesis[5][6][8]. The combination could theoretically be used when both antimicrobial action against intestinal pathogens (paromomycin) and prokinetic/antiemetic effects (domperidone) are desired.

02

Targets

DRD2 (Dopamine D2 Receptor)30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on paromomycin + domperidone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paromomycin + domperidone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call